Abstract
In this work, the biological effects of diethylnitrosamine (DENA) have been studied under controlled conditions of its metabolism in mice of different ages. The results indicate that the general toxic and hepatocarcinogenic effects of DENA are mostly due to the parent compound, whereas the alkylating metabolites cause hepatic cell damage. Our findings cast doubt on the conventional understanding of the exclusive role of mutagenic activation in the carcinogenic action of chemicals.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- DENA:
-
diethylnitrosamine
- DMNA:
-
dimeth-ylnitrosamine
- CYP2E1:
-
cytochrome P450 2E1
References
P. N. Magee and J. M. Barnes, Adv. Cancer Res. 10, 164 (1967).
R. Preussmann and B. W. Stewart, in: Chemical Carcinogens, ACS Monograph 182, Ed. by C. T. Searle (Washington, 1984), pp. 643–828.
V. S. Turusov, G. A. Belitskii, L. N. Pylev, and V. A. Koblyakov, in Rarcinogenesis, Ed. by D. G. Zaridze (Meditsina, Moscow, 2004), pp. 204–225 [in Russian].
J. S. Kang, H. Wanibuchi, K. Morimura, et al., Cancer Res. 67, 11141 (2007).
R. Daoust and R. Morais, Chem.-Biol. Interact. 57, 55 (1986).
J-S. H. Yoo, H. Ishizaki, and C. S. Yang, Carcinogenesis 11, 2239 (1990).
F. P. Guengerich, D. H. Kim, and M. Ivasaki, Chem. Res. Toxicol. 14, 168 (1991).
R. A. McKinnon and D. W. Nebert, Clin. Expt. Pharmacol. Physiol. 25, 783 (1998).
F. J. Gonzalez, Drug Metab. Dispos. 35, 1 (2007).
A. Takada, J. Nei, S. Takase, and Y. Matsuda, Hepatology 6, 65 (1986).
M. Schwars, A. Buchmann, G. Wiesbeck, and W. Kunz, Cancer Lett. 20, 305 (1983).
D. Schmahl, C. Thomas, W. Sattler, and G. F. Scheld, Z. Krebforsch. 66, 526, (1965).
M. Habs and D. Schmahl, Hepato-Gastroenterology 28, 242 (1981).
E. A. Porta, N. Markell, and R. D. Dorado, Hepatology 6, 1120 (1985).
F. Stickler, D. Schuppan, E. G. Hahn, and H. K. Seitz, Gut 51, 132 (2002).
R. Peng, Y.-Y. Tu, and C. Yang, Carcinogenesis 3, 1457 (1982).
B. J. Song, R. L. Veech, S. S. Park, et al., J. Biol. Chem. 264, 3568 (1989).
N. Kurata, H. E. Hurst, F. W. Benz, et al., Drug Metabol. Dispos. 9, 388 (1991).
B. J. Roberts, S. E. Shoaf, and B. J. Song, Biochem. Pharmacol. 49, 665 (1995).
Y. Hu, M. Ingelman-Sundberg, and K. O. Lindros, Biochem. Pharmacol. 50, 155 (1995).
T. K. Chang, C. L. Crespi, and D. J. Waxman, Methods Mol. Biol. 320, 127 (2006).
I. Y. Chau, D. Dagani, M. C. Archer, J. Nat. Cancer Inst. 61, 517 (1978).
Y. J. Lee, A. R. Aroor, and S. D. Shukla, J. Pharmacol. Exp. Ther. 301, 908 (2002).
G. M. Williams, M. Klaibe, S. E. Parker, and E. Farber, J. Nat. Cancer Inst. 56, 196 (1976).
V. I. Kaledin, S. I. Ilnitskaya, N. I. Baginskaya, et al., Ross. Fiziol. Zh. im. I.M. Sechenova 91, 1481 (2005).
P. Quillardet and M. Hofnung, Mutat. Res. 147, 65 (1985).
L. P. Ovchinnikova, L. A. Bogdanova, and V. I. Kaledin, Byull. Eksp. Biol. Med. 154, 623 (2012).
W. Lijinsky, Chemistry and Biology of N-Nitroso Compounds (Cambridge Univ. Press, New York, 1992).
V. I. Kaledin, E. A. Vasyunina, L. P. Ovchinnikova, et al., Inf. Vestn. Vavilovskogo O–va. Genet. Sel. 21–22, 11 (2002).
T. I. Merkulova, K. Y. Kropachev, O. A. Timofeeva, et al., Mol. Carcinog. 44, 223 (2005).
O. A. Timofeeva, A. V. Eremeev, A. Goloschapov, et al., Toxicology 254, 91 (2008).
V. I. Kaledin, S. I. Ilnitskaya, L. P. Ovchinnikova, et al., Biophysics (Moscow) 59, 431 (2014).
V. I. Kaledin, S. I. Ilnitskaya, N. A. Popova, et al., Biophysics (Moscow) 59, (635) (2014).
V. I. Kaledin, N. A. Popova, V. P. Nikolin, et al., Free Radic. Res. 43, 685 (2009).
T. Suzuki, M. Imagava, R. Yamada, et al., Carcinogenesis 15, 1759 (1994).
V. I. Kaledin, M. Y. Pakharukova, E. N. Pivovarova, et al., Biophysics 55, 275 (2010).
J. S. Kang, J. Biomed. Res. 13, 339 (2012).
H. Yamasaki, Y. Inui, C. H. Yun, et al., Carcinogenesis 13, 1789 (1992).
A. M. Camus, O. Geneste, P. Honkakoski, et al., Mol. Carcinog. 7, 268 (1993).
J. Y. Cui, H. J. Renand, and K. D. Klaassen, Drug Metab. Dispos. 40, 1226 (2012).
E. Albano, A. Tomaai, J.-O. Persson, et al., Biochem. Pharmacol. 41, 1895 (1991).
N. Nieto, S. L. Friedman, P. Greenwel, and A. J. Cederbaum, Hepatology 30, 987 (1999).
H. Liu, B. F. Jones, C. Bradham, and M. J. Cizaia, Am. J. Physiol. Gastrointest. Liver Physiol. 282, 257 (2002).
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.I. Kaledin, S.I. Ilnitskaya, E.A. Vasyunina, N.A. Popova, L.A. Bogdanova, M.L. Perepechaeva, A.Y. Grishanova, 2015, published in Biofizika, 2015, Vol. 60, No. 6, pp. 1166–1173.
The article was translated by the authors.
Rights and permissions
About this article
Cite this article
Kaledin, V.I., Ilnitskaya, S.I., Vasyunina, E.A. et al. The effect of changes in CYP2E1 activity in the liver on toxicity and carcinogenicity of diethylnitrosamine in mice. BIOPHYSICS 60, 970–976 (2015). https://doi.org/10.1134/S0006350915060123
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006350915060123